Atrys Health SL

Price Chart

Risk-Adjusted Performance

Atrys Health SL (ATRY) Price Performance

Atrys Health SL (ATRY) trades on Bolsa de Madrid in EUR. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at EUR3.01, down 0.99% from the previous close.

Over the past year, ATRY has traded between a low of EUR2.51 and a high of EUR3.51. The stock has gained 4.9% over this period. It is currently 14.2% below its 52-week high.

Atrys Health SL has a market capitalization of $228.50M.

About Atrys Health SL

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.